홈 › 교모세포종 › 캘리포니아 › Los Angeles
CA Los Angeles의 교모세포종 임상 시험
교모세포종 관련 연구 24개가 Los Angeles 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
피험자 모집 중3상
- Kaiser Permanente, Los Angeles
- UCLA, Los Angeles
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
피험자 모집 중3상
- Keck Medicine of USC, Los Angeles
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
피험자 모집 중1/2상
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
피험자 모집 중2/3상
- Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
피험자 모집 중2상
- Cedars-Sinai Medical Center, Los Angeles
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
피험자 모집 중1/2상
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
피험자 모집 중1/2상
- University of Southern California, Los Angeles
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
피험자 모집 중1/2상
- Cedars-Sinai Medical Center, Los Angeles
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
피험자 모집 중1상
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
피험자 모집 중3상
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
피험자 모집 중1/2상
- UCLA Health Bowyer Oncology Center, Los Angeles
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
피험자 모집 중1상
- University of California, Los Angeles (Data Collection Only), Los Angeles
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
피험자 모집 중3상
- University of California, Los Angeles, Los Angeles
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
피험자 모집 중2상
- Cedars-Sinai Medical Center, Los Angeles
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
피험자 모집 중2상
- Cedars-Sinai Medical Center, Los Angeles
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
피험자 모집 중1상
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
PH Sensitive MRI Based Resections of Glioblastoma
피험자 모집 중1상
- Ronald Reagan Medical Center, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
피험자 모집 중
- Oncology Institute for Hope and Innovation, Los Angeles
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
피험자 모집 중1/2상
- University of California Los Angeles, Los Angeles
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
피험자 모집 중3상
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
피험자 모집 중
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
피험자 모집 중1/2상
- University of California at Los Angeles, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
피험자 모집 중1/2상
- Cedars Sinai Medical Center, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
피험자 모집 중2상
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
다른 도시의 교모세포종 시험
- New York City, NY연구 30개
- Boston, MA연구 28개
- Houston, TX연구 26개
- Durham, NC연구 20개
- San Francisco, CA연구 17개
- Chicago, IL연구 15개
- Washington, DC연구 15개
- Miami, FL연구 14개
- Columbus, OH연구 14개
- Rochester, MN연구 13개
- Jacksonville, FL연구 13개
- Aurora, CO연구 12개
Los Angeles의 다른 연구
- 비소세포폐암연구 87개
- 암 (전체)연구 74개
- 유방암연구 73개
- 전립선암연구 61개
- 대장직장암연구 59개
- 전이성 암연구 57개
- 난소암연구 50개
- 폐암연구 45개
- 두경부 편평세포암연구 42개
- 췌장암연구 35개
- 자궁내막암연구 34개
- 흑색종연구 34개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.